Langerhans cell histiocytosis (LCH): investigations
Evidence-based neurology checklist on langerhans cell histiocytosis (lch): investigations: Pathological features The histiocytic cells originate from bone marrow-derived immature myeloid dendritic cells They are S‐100, CD1a, and CD207 (Langerin) positive cells They have abundant eosinophilic…
Pathological features
- The histiocytic cells originate from bone marrow-derived immature myeloid dendritic cells
- They are S‐100, CD1a, and CD207 (Langerin) positive cells
- They have abundant eosinophilic cytoplasm
- There appear as Birbeck granules on electron microscopy:
Haematological tests
Endocrine tests
Pulmonary tests
Cardiac tests
Gastrointestinal and hepatobiliary tests
Molecular analysis
Magnetic resonance imaging (MRI) brain: features
Other imaging tests
Other tests
Synonym
References
- Satter EK, High WA. Langerhans cell histiocytosis: a review of the current recommendations of the Histiocyte Society. Pediatr Dermatol 2008; 25:291-295.
- Leung AKC, Lam JM, Leong KF. Childhood Langerhans cell histiocytosis: a disease with many faces. World J Pediatr 2019; 15:536-545.
- Girschikofsky M, Arico M, Castillo D, et al. Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net.Orphanet J Rare Dis 2013; 8:72.
- Harmon CM, Brown N. Langerhans cell histiocytosis: a clinicopathologic review and molecular pathogenetic update. Arch Pathol Lab Med 2015; 139:1211-1214.
- Goyal G, Tazi A, Go RS, et al. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood 2022; 139:2601-2621.
